Operating Expenses Cambiamento Data
Gilead Sciences USD 5.5B 1.08B 2023-12
RedHill Biopharma USD 6.2M 31.68M 2023-06
Supernus Pharmaceuticals USD 165.31M 19.57M 2023-12



Intra Cellular Therapies Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.